Atorvastatin Calcium Tablet
Product Images NDC 60290-040

This text appears to be a statistical comparison between the outcomes of two groups, one treated with Atorvastatin and the other with Placebo. The cumulative incidence of an event is presented as a percentage. The Hazard Ratio (HR) indicated is 0.64 with a 95% confidence interval of 0.50 to 0.83, and a p-value of 0.0005. The data is presented over a span of 35 years. The statistical analysis suggests a significant difference in outcomes between the two groups.*

This text provides data on the cumulative hazard percentage and the comparison between placebo and Atorvastatin in terms of hazard ratio (HR), confidence interval (0.48-0.83), and p-value. It also mentions the time to the first primary endpoint through four years of follow-up.*

This text provides data on the percentage of subjects experiencing an event in relation to different doses of Atorvastatin (10 mg and 80 mg). It also indicates a hazard ratio of 0.78 (with confidence interval) and associated P-value. Additionally, it mentions the time to the first major cardiovascular endpoint in years.*

This text provides information about Atorvastatin Calcium tablets, each containing 10 mg of Atorvastatin. It mentions the National Drug Code (NDC) 60290-039-02 and includes details such as dosage, usage, and manufacturer information. It also indicates where to find patient information and the website for further details. The tablets are meant for prescription use only and are distributed by Umedica Laboratories USA Inc. in Parsippany, NJ.*

This text contains information about Atorvastatin Calcium tablets, equivalent to 10 mg of Atorvastatin. It provides storage instructions, dosage information, and a warning about keeping the package child-resistant. The text also includes details about the manufacturer and distributor. Patient information is available online and the product is categorized as prescription-only. Further details such as NDC, Rx information, manufacturing location, and lot numbers are also present.*

This text provides information about Atorvastatin Calcium tablets containing 20mg of Atorvastatin. The tablets are manufactured by Umedica Laboratories Pvt. Ltd. in India and distributed by Umedica Laboratories USA Inc. in Parsippany, NJ. It includes dosage and usage instructions and a link for patient information. The tablets are available by prescription only and come in a pack of 1000 tablets. The GTIN and lot number are also provided for tracking purposes.*

This text provides detailed information about Atorvastatin Calcium tablets containing 20 mg of Atorvastatin per tablet, to be stored at room temperature. It includes dosage, usage instructions, details on dispensing, child-resistant packaging, and where to find patient information. The tablets are manufactured in India and distributed by Umedica Laboratories in the USA. The text also includes regulatory information such as NDC, lot number, and expiry date. For comprehensive prescribing information or patient assistance, the package insert or the website provided can be referenced.*

This text provides detailed information about Atorvastatin Calcium tablets containing 40 mg of Atorvastatin. The tablets should be stored at room temperature and dispensed in a tight container. It also includes dosage instructions, safety precautions for children, a reference to the package insert for full prescribing information, and a link to patient information. The product is distributed by Umedica Laboratories USA Inc., manufactured in India by Umedica Laboratories Pvt. Ltd., and is specific for prescription use only. The text includes important regulatory details such as NDC, manufacturing license number, and batch information. For further details, visit the provided link.*

This is a description of Atorvastatin Calcium USP tablets. Each tablet contains a specific amount of Atorvastatin Calcium USP. The tablets should be stored at a controlled room temperature of 20°C-25°C (68°F-77°F) and dispensed in a tight container as per USP guidelines. The package includes dosing instructions and directs to a website for additional patient information. The packaging is child-resistant and should be kept away from children. The tablets are for prescription use only and come in a pack of 90 tablets. The product is manufactured in India by Umedica Laboratories Pvt. Ltd. and distributed in the USA by Umedica Laboratories USA Inc. The package includes relevant identification details such as NDC, Rev, GTIN, SN, EXP, and LOT numbers for tracking and quality control purposes.*

This text is a detailed description of Atorvastatin Calcium tablets, with each tablet containing 80 mg of Atorvastatin. The manufacturing information includes Umedica Laboratories Pvt. Ltd. in Vapi, Gujarat, India. The tablets are to be stored at controlled room temperature, and the product is distributed by Umedica Laboratories USA Inc. The dosage instructions advise referring to the package insert for full prescribing information. Patients are instructed to keep the tablets out of reach of children. Additional patient information can be found at the provided website. This product is labeled for prescription use only and comes in a package containing 1000 tablets.*